175 related articles for article (PubMed ID: 9268227)
1. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation.
Erşahin C; Simmons WH
J Cardiovasc Pharmacol; 1997 Jul; 30(1):96-101. PubMed ID: 9268227
[TBL] [Abstract][Full Text] [Related]
2. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.
Prechel MM; Orawski AT; Maggiora LL; Simmons WH
J Pharmacol Exp Ther; 1995 Dec; 275(3):1136-42. PubMed ID: 8531074
[TBL] [Abstract][Full Text] [Related]
3. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart.
Dendorfer A; Wolfrum S; Wellhöner P; Korsman K; Dominiak P
Br J Pharmacol; 1997 Nov; 122(6):1179-87. PubMed ID: 9401784
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin metabolism in the isolated perfused rabbit heart.
Taylor-McCabe KJ; Erşahin C; Simmons WH
J Hypertens; 2001 Jul; 19(7):1295-9. PubMed ID: 11446720
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of the aminopeptidase P inhibitor apstatin: studies on ischemia/reperfusion injury in the isolated rat heart.
Erşahin C; Euler DE; Simmons WH
J Cardiovasc Pharmacol; 1999 Oct; 34(4):604-11. PubMed ID: 10511138
[TBL] [Abstract][Full Text] [Related]
6. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
[TBL] [Abstract][Full Text] [Related]
7. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.
DelBel EA; Padovan AP; Padovan GJ; Sellinger OZ; Martins AR
Cell Mol Neurobiol; 1989 Sep; 9(3):379-400. PubMed ID: 2558804
[TBL] [Abstract][Full Text] [Related]
10. Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses.
Kitamura S; Carbini LA; Simmons WH; Scicli AG
Am J Physiol; 1999 May; 276(5):H1664-71. PubMed ID: 10330252
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin.
Ryan JW; Berryer P; Chung AY; Sheffy DH
J Pharmacol Exp Ther; 1994 Jun; 269(3):941-7. PubMed ID: 8014881
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of bradykinin by the rat coronary vascular bed.
Dumoulin MJ; Adam A; Blais C; Lamontagne D
Cardiovasc Res; 1998 Apr; 38(1):229-36. PubMed ID: 9683926
[TBL] [Abstract][Full Text] [Related]
13. Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart.
Ahmad M; Zeitlin IJ; Parratt JR; Pitt AR
Arch Pharm Res; 2006 Mar; 29(3):241-8. PubMed ID: 16596998
[TBL] [Abstract][Full Text] [Related]
14. Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates.
Oliveira EB; Souza LL; Sivieri DO; Bispo-da-Silva LB; Pereira HJ; Costa-Neto CM; Sousa MV; Salgado MC
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3550-7. PubMed ID: 17906107
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts.
Blais C; Fortin D; Rouleau JL; Molinaro G; Adam A
J Pharmacol Exp Ther; 2000 Nov; 295(2):621-6. PubMed ID: 11046097
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans.
Kim KS; Kumar S; Simmons WH; Brown NJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):295-8. PubMed ID: 10604961
[TBL] [Abstract][Full Text] [Related]
17. Degradation of bradykinin in semen of ram and boar.
Boettger A; Kertscher U; Steinmann C; Baeger U; Siems WE; Heder G
Biochem Pharmacol; 1993 May; 45(10):1983-8. PubMed ID: 8390257
[TBL] [Abstract][Full Text] [Related]
18. Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts.
Schölkens BA; Linz W
Clin Exp Hypertens A; 1988; 10(6):1259-70. PubMed ID: 2975971
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
Ward PE; Chow A; Drapeau G
Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
[TBL] [Abstract][Full Text] [Related]
20. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
Hecker M; Pörsti I; Bara AT; Busse R
Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
